Literature DB >> 8615581

Vocal fold atrophy and its surgical treatment.

N Isshiki1, K Shoji, H Kojima, S Hirano.   

Abstract

The effectiveness of surgical treatment for vocal fold atrophy of various causes was examined. Type I thyroplasty was performed on 31 patients with vocal fold atrophy, often bilaterally and occasionally combined with type III thyroplasty. Of these 31 patients, 3 patients underwent the operation twice, for a total of 34 operations. The surgery was found to be effective in improving the voice quality and the ease of phonation. When a scar or sulcus was present, the results were not as satisfactory. The intraoperative decision-making process as to which procedure to perform is extremely important for achieving an optimal voice, and should be based on the intraoperative voice quality, fiberoptic findings, and manual tests. In operations for vocal fold atrophy in which the vocal folds are mobile, a silicone shim should be firmly fixed to prevent migration. Overcorrection is generally recommended. No complications were encountered. It was often the increased ease of phonation rather than the improved voice quality that patients appreciated after surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8615581     DOI: 10.1177/000348949610500303

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  13 in total

Review 1.  Technical considerations in fat augmentation for patients with glottic insufficiency.

Authors:  Ming-Wang Hsiung
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

Review 2.  Sulcus vocalis: a review.

Authors:  Antoine Giovanni; Cécile Chanteret; Aude Lagier
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-13       Impact factor: 2.503

3.  Over-injection of autologous fat in the vocal fold: how to remove the excess?

Authors:  Mari Nakamura; Ryoji Tokashiki; Nobuhiko Issiki; Hiroyuki Hiramatu; Hidenori Kanazawa; Ray Motohashi; Mamoru Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-05-27       Impact factor: 2.503

Review 4.  Vocal fold scars: current concepts and future directions. Consensus report of the Phonosurgery Committee of the European Laryngological Society.

Authors:  G Friedrich; F G Dikkers; C Arens; M Remacle; M Hess; A Giovanni; S Duflo; A Hantzakos; V Bachy; M Gugatschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-21       Impact factor: 2.503

5.  Effects of Age and Parkinson's Disease on the Relationship between Vocal Fold Abductory Kinematics and Relative Fundamental Frequency.

Authors:  Jennifer M Vojtech; Cara E Stepp
Journal:  J Voice       Date:  2022-04-05       Impact factor: 2.300

6.  Autogenous fat injection for vocal fold atrophy.

Authors:  Ming-Wang Hsiung; Yaoh-Shiang Lin; Wan-Fu Su; Hsing-Won Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

Review 7.  Tissue engineering-based therapeutic strategies for vocal fold repair and regeneration.

Authors:  Linqing Li; Jeanna M Stiadle; Hang K Lau; Aidan B Zerdoum; Xinqiao Jia; Susan L Thibeault; Kristi L Kiick
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

8.  Biocompatibility of injectable resilin-based hydrogels.

Authors:  Linqing Li; Jeanna M Stiadle; Elizabeth E Levendoski; Hang K Lau; Susan L Thibeault; Kristi L Kiick
Journal:  J Biomed Mater Res A       Date:  2018-05-11       Impact factor: 4.396

9.  Restoration of diaphragmatic function after diaphragm reinnervation by inferior laryngeal nerve; experimental study in rabbits.

Authors:  Stephane Derrey; Eric Verin; Annie Laquerrière; Angelique Boishardy de Barros; Yann Lacoume; Pierre Fréger; Jean Paul Marie
Journal:  Respir Res       Date:  2006-01-27

10.  Regeneration of Vocal Fold Mucosa Using Tissue-Engineered Structures with Oral Mucosal Cells.

Authors:  Mioko Fukahori; Shun-Ichi Chitose; Kiminori Sato; Shintaro Sueyoshi; Takashi Kurita; Hirohito Umeno; Yu Monden; Ryoji Yamakawa
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.